Stay updated on Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the record history. Outdated notices including a funding-status warning and Revision: v3.4.1 were removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:43:36.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice regarding government funding and updated the page revision to v3.4.1, while the previous revision v3.4.0 was deleted. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:22:07.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The new version adds UI elements to the history page (color-coded additions/deletions) and shows that results were posted, along with references to new sections like Limitations and Caveats and Outcome Measures (Results).
    Difference
    0.8%
    Check dated 2026-01-28T03:20:05.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A new revision, v3.3.4, was added to the record history and the previous revision v3.3.3 was removed.
    Difference
    0.0%
    Check dated 2026-01-14T01:57:43.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T12:47:13.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    New and updated major study data sections have been added, including Adverse Events, Outcome Measures (Results), Baseline Characteristics, and Participant Flow. The latest version shows Returned: 2025-12-09 and QC review not concluded.
    Difference
    0.7%
    Check dated 2025-12-16T03:04:17.000Z thumbnail image

Stay in the know with updates to Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page.